Brian Vastag (@brianvastag@mas.to)
Kaufman: Most of my patients using it are long covid patients. Their responsiveness may be significant...it's a shorter course of illness than long-term ME/CFS patients with a very definite infectious cause of their illness.

"Kaufman: Most of my patients using it are long covid patients. Their responsiveness may be significant...it's a shorter course of illness than long-term ME/CFS patients with a very definite infectious cause of their illness."
i.e. a group of patients who might be more likely to recover/improve anyway?